$339.50 +12.52 (%) Allergan PLC - NYSE

Jul. 28, 2015 | 04:00 PM

Partner Headlines

  1. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD | Jul. 28, 2015 | 14:33PM EST
  2. Stocks In Rebound Mode; Icon, Cadence Break Out

    IBD | Jul. 28, 2015 | 13:36PM EST
  3. Is More M&A On The Way For Large-Cap Biotechs?

    Benzinga | Jul. 28, 2015 | 13:18PM EST
  4. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 13:08PM EST
  5. Teva Still A 'Must-Own' Stock, Worth $86

    Benzinga | Jul. 28, 2015 | 09:15AM EST
  6. Mandel's Lone Pine Takes Stake in Growing Horizon Pharma

    GuruFocus | Jul. 28, 2015 | 02:14AM EST
  7. Teva Prefers Allergan Unit

    IBD | Jul. 27, 2015 | 18:56PM EST
  8. Benzinga's M&A Chatter for Monday July 27, 2015

    Benzinga | Jul. 27, 2015 | 18:39PM EST
  9. Why The $40.5 Billion Acquisition Of Allergan's Generic Business For Teva Is 'Right Deal At The Right Time'

    Benzinga | Jul. 27, 2015 | 16:49PM EST
  10. Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA

    Benzinga | Jul. 27, 2015 | 16:45PM EST
  11. Stocks Fall For Fifth Straight Session On China Woes

    IBD | Jul. 27, 2015 | 16:39PM EST
  12. With The Teva Money, Allergan Could Engage In 'Large M&A' Next: Evercore ISI

    Benzinga | Jul. 27, 2015 | 16:25PM EST
  13. Allergan CEO: Teva Made A 'Compelling Offer' We Couldn't Refuse

    Benzinga | Jul. 27, 2015 | 15:19PM EST
  14. Stocks Mired In Red, Hurt By China Weakness; Boot Barn Bounces

    IBD | Jul. 27, 2015 | 13:37PM EST
  15. Chardan's Take On Axovant, Avalanche & VistaGen

    Benzinga | Jul. 27, 2015 | 12:47PM EST
  16. Market Update: Monday's Mid-Day Movers, China's Stock Market Crash And More

    Benzinga | Jul. 27, 2015 | 12:36PM EST
  17. Teva Buys Allergan Unit: How Mylan, Other Biotech Stocks Are Reacting

    Benzinga | Jul. 27, 2015 | 12:08PM EST
  18. Stocks In The Red But Off Lows As Shanghai, Europe Weigh

    IBD | Jul. 27, 2015 | 11:57AM EST
  19. Teva Drops Mylan Chase To Buy Allergan Generics Unit

    IBD | Jul. 27, 2015 | 10:51AM EST
  20. Benzinga's Volume Movers

    Benzinga | Jul. 27, 2015 | 10:23AM EST
  21. Morning Market Losers

    Benzinga | Jul. 27, 2015 | 09:50AM EST
  22. Morning Market Gainers

    Benzinga | Jul. 27, 2015 | 09:39AM EST
  23. Teva Confirms Allergan Generics Buy, Drops Mylan Bid

    IBD | Jul. 27, 2015 | 09:10AM EST
  24. U.S. Stocks On Track For Weak Open As Chinese Stocks Sink

    IBD | Jul. 27, 2015 | 08:59AM EST
  25. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 27, 2015 | 08:22AM EST
  26. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 27, 2015 | 08:13AM EST
  27. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jul. 27, 2015 | 07:07AM EST
  28. UPDATE: Mylan Issues Comment on Teva Deal to Buy Allergan's Generic Drug Unit

    Benzinga | Jul. 27, 2015 | 06:43AM EST
  29. UPDATE: Teva to Acquire Allergan Generics for $40.5 B

    Benzinga | Jul. 27, 2015 | 04:32AM EST
  30. Stocks To Watch For July 27, 2015

    Benzinga | Jul. 27, 2015 | 04:18AM EST
  31. Benzinga's Weekend M&A Chatter

    Benzinga | Jul. 26, 2015 | 20:26PM EST
  32. Teva To Buy Allergan's Generic Drug Unit, Unit Worth ~$45B, Deal May Be Announced Monday

    Benzinga | Jul. 25, 2015 | 18:03PM EST
  33. Benzinga's Top Downgrades

    Benzinga | Jul. 17, 2015 | 09:47AM EST
  34. RBC Capital Downgrades Allergan, But Still Keeps It As 'Core' Holding

    Benzinga | Jul. 17, 2015 | 08:10AM EST
  35. Which Top Biotechs Still In Play After Celgene Rally?

    IBD | Jul. 16, 2015 | 18:45PM EST
  36. Top World Stocks In Bases Or Buy Range As Greece Votes

    IBD | Jul. 15, 2015 | 17:50PM EST
  37. Allergan Notes Receipt of Paragraph IV Notification on Restasis

    Benzinga | Jul. 15, 2015 | 16:02PM EST
  38. Teva-Mylan merger opposed

    IBD | Jul. 14, 2015 | 18:37PM EST
  39. Allergan, Celgene Break Out As Other Medicals Base

    IBD | Jul. 13, 2015 | 18:43PM EST
  40. IBD 50 Security, Semiconductor Stocks Under Fire

    IBD | Jul. 10, 2015 | 19:00PM EST
  41. Can This Top-Rated Drugmaker Land Another Big Buy?

    IBD | Jul. 9, 2015 | 18:27PM EST
  42. Four Leading Stocks With New Base Patterns To Watch

    IBD | Jul. 9, 2015 | 18:27PM EST
  43. Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz

    Benzinga | Jul. 9, 2015 | 08:56AM EST
  44. Foreign Drugmakers Seen Posting Big Earnings Increases

    IBD | Jul. 8, 2015 | 18:30PM EST
  45. The Worst Foreign Stock Performers Today As Global Markets Freeze

    IBD | Jul. 7, 2015 | 18:13PM EST
  46. Carter Worth Is Bullish Mohawk Industries, Allergan And Morgan Stanley

    Benzinga | Jul. 7, 2015 | 06:45AM EST
  47. Allergan Is Buying Its Way To Growth

    IBD | Jul. 2, 2015 | 18:54PM EST
  48. Top Takeaways From BMO's Specialty Pharma Day

    Benzinga | Jul. 1, 2015 | 13:13PM EST
  49. Leerink Downgrades Kythera, Says Allergan Deal Likely To Close At $75 Mark

    Benzinga | Jun. 29, 2015 | 07:46AM EST
  50. Acquisition in the Health Care Industry Increased Volatility

    GuruFocus | Jun. 27, 2015 | 20:15PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!